0001415889-22-002085.txt : 20220301 0001415889-22-002085.hdr.sgml : 20220301 20220301201359 ACCESSION NUMBER: 0001415889-22-002085 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220226 FILED AS OF DATE: 20220301 DATE AS OF CHANGE: 20220301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lloyd Brian G. CENTRAL INDEX KEY: 0001671772 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18592 FILM NUMBER: 22700768 MAIL ADDRESS: STREET 1: 1600 WEST MERIT PARKWAY CITY: SOUTH JORDAN STATE: UT ZIP: 84095 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIT MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000856982 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870447695 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1600 WEST MERIT PARK WAY CITY: SOUTH JORDAN STATE: UT ZIP: 84095 BUSINESS PHONE: 8012531600 MAIL ADDRESS: STREET 1: 1600 WEST MERIT PARKWAY CITY: SOUTH JORDAN STATE: UT ZIP: 84095 4 1 form4-03012022_050344.xml X0306 4 2022-02-26 0000856982 MERIT MEDICAL SYSTEMS INC MMSI 0001671772 Lloyd Brian G. 1600 WEST MERIT PARKWAY SOUTH JORDAN UT 84095 false true false false CHIEF LEGAL OFFICER, SECRETARY Common Stock, No Par Value 2022-02-26 4 A 0 6630 0 A 11476 D Common Stock, No Par Value 2022-02-28 4 F 0 1942 65.03 D 9534 D Non-qualified stock options (right to buy) 65.03 2022-02-26 4 A 0 8094 0 A 2023-02-28 2029-02-28 Common Stock 8094 8094 D Non-qualified stock options (right to buy) 56.25 2022-03-19 2028-03-19 Common Stock 9681 9681 D Non-qualified stock options (right to buy) 28.2 2018-04-14 2024-04-14 Common Stock 30000 30000 D Non-qualified stock options (right to buy) 44.8 2019-03-02 2025-03-02 Common Stock 25000 25000 D Non-qualified stock options (right to buy) 55.73 2020-03-01 2026-03-01 Common Stock 30000 30000 D Non-qualified stock options (right to buy) 37.71 2021-02-26 2027-02-26 Common Stock 16722 16722 D These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/26/2020. Becomes exercisable in equal annual installments of 25% commencing 02/28/2023. Become exercisable in equal annual installments of 25% commencing on 03/19/2022. Become exercisable in equal annual installments of 20% commencing on 04/14/2018. The Form 5 filed on 02/14/2022 incorrectly reported the underlying shares for this holding. Become exercisable in equal annual installments of 20% commencing on 03/02/2019. Become exercisable in equal annual installments of 20% commencing on 03/01/2020. Become exercisable in equal annual installments of 25% commencing on 02/26/2021. /s/ Brian G. Lloyd 2022-03-01